dacarbazine has been researched along with trelstar in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balasch, J; Camus, A; Castelo-Branco, C; Martínez de Osaba, MJ; Mercadal, S; Nomdedeu, B | 1 |
Attilio, G; Cristina, L; Edoardo, DN; Giuseppe, L; Loredana, G; Vincenzo, L | 1 |
Arigita, M; Balasch, J; Castelo-Branco, C; Durán, M; Nomdedeu, B; Rabanal, A | 1 |
2 trial(s) available for dacarbazine and trelstar
Article | Year |
---|---|
Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Density; Cyclophosphamide; Dacarbazine; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Norpregnenes; Ovary; Prednisone; Primary Ovarian Insufficiency; Procarbazine; Triptorelin Pamoate; Vinblastine; Vincristine | 2007 |
Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Topics: Adolescent; Adult; Amenorrhea; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Female; Follicle Stimulating Hormone; Glycoproteins; Hodgkin Disease; Humans; Infertility, Female; Inhibins; Luteinizing Hormone; Mechlorethamine; Ovarian Follicle; Ovary; Predictive Value of Tests; Prednisolone; Prednisone; Primary Ovarian Insufficiency; Procarbazine; Sensitivity and Specificity; Survivors; Testicular Hormones; Time Factors; Triptorelin Pamoate; Ultrasonography; Vinblastine; Vincristine | 2007 |
1 other study(ies) available for dacarbazine and trelstar
Article | Year |
---|---|
Unintended pregnancy after gonadal failure chemoprevention with gonadotropin-releasing hormone agonist in women with hematologic malignancies.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Dacarbazine; Doxorubicin; Female; Gonadotropin-Releasing Hormone; Hematologic Neoplasms; Humans; Infant, Newborn; Middle Aged; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy, Unplanned; Primary Ovarian Insufficiency; Time Factors; Triptorelin Pamoate; Vinblastine; Young Adult | 2009 |